Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Octreotide Acetate Long-Acting Formulation Versus Open-Label Subcutaneous Octreotide Acetate in Malignant Carcinoid Syndrome

PaperCitations, authors & open-access status

Octreotide Acetate Long-Acting Formulation Versus Open-Label Subcutaneous Octreotide Acetate in Malignant Carcinoid Syndrome is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 389 citations, 1999 year and closed oa status.

389
Citations
1999
Year
closed
OA Status

Related on ScholarIQ

Rodney F. Pommier
Author
Journal of Clinical Oncology
Journal
Neuroendocrine Tumor Research Advances
Topic
Neuroendocrine Tumor Research Advances
Topic
Pituitary Gland Disorders and Treatments
Topic
Pancreatitis Pathology and Treatment
Topic
470M+ articles · free account